Generation Bio CO 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Generation Bio Co. focuses on developing redosable therapeutics for T cell-driven autoimmune diseases, leveraging its ctLNP delivery system and siRNA technology.
Generation Bio Co.'s 10-K filing details its advancements in non-viral genetic medicine platforms and strategic reorganization to focus on key programs.